ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fibromyalgia and population studies"

  • Abstract Number: 1106 • 2014 ACR/ARHP Annual Meeting

    Most Patients Diagnosed with Fibromyalgia By Physicians Do Not Have Fibromyalgia: The 2012 National Health Interview Survey Fibromyalgia Study

    Brian Walitt1, Richard Nahin2, Robert S. Katz3, Martin J. Bergman4 and Frederick Wolfe5, 1MedStar Health, Washington, DC, 2National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethedsa, MD, 3Rush Medical College, Chicago, IL, 4Taylor Hospital, Ridley Park, PA, 5National Data Bank for Rheumatic Diseases, Wichita, KS

    Background/Purpose: Although criteria exist for fibromyalgia (FM) diagnosis, little is known about how FM diagnosis is applied and understood by physicians and patients in the…
  • Abstract Number: 896 • 2014 ACR/ARHP Annual Meeting

    Development of Fibromyalgia and Polysymptomatic Distress Definitions in the National Health Interview Survey

    Brian Walitt1, Richard Nahin2, Robert S. Katz3, Martin J. Bergman4 and Frederick Wolfe5, 1MedStar Health, Washington, DC, 2National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethedsa, MD, 3Rush Medical College, Chicago, IL, 4Taylor Hospital, Ridley Park, PA, 5National Data Bank for Rheumatic Diseases, Wichita, KS

    Background/Purpose: A detailed understanding of fibromyalgia and its symptoms in the US population would be valuable. The National Health Interview Survey (NHIS) is the principal…
  • Abstract Number: 137 • 2013 ACR/ARHP Annual Meeting

    A Population-Based Survey and Physician Assessment Of The Characteristics and Prevalence Of Fibromyalgia

    Edgar H. Adams1, Shoshana Daniel2, Arthi B. Chandran3, Heather McElroy4, Caroline Schaefer1, Rachael Mann5, Gergana Zlateva3, Joseph C. Cappelleri6, Elizabeth T. Masters7, Annlouise R. Assaf6, Michael McNett8, Stuart L. Silverman9, Roland Staud10 and Philip Mease11, 1Covance Market Access Services Inc., Gaithersburg, MD, 2Covance Market Access Services Inc., Conshohocken, PA, 3Pfizer Inc., New York, NY, 4Covance Market Access Services, Sydney, Australia, 5Covance Market Access Services Inc., San Diego, CA, 6Pfizer Inc., Groton, CT, 7Pfizer Inc, New York, NY, 8Aurora Pain Program, Milwaukee, WI, 9Cedars-Sinai Medical Center, UCLA Center of Excellence, Los Angeles, CA, 10Dept Med/Rheum/Clin Immun Div, University of Florida, Gainesville, FL, 11Director, Rheumatology Research, Swedish Medical Center, Seattle, WA

    Background/Purpose: No large-scale, national study estimating fibromyalgia (FM) prevalence in the United States (US) has been conducted involving physician evaluation.  The study objective was to…
  • Abstract Number: 1859 • 2012 ACR/ARHP Annual Meeting

    The Polysymptomatic Distress Scale and the Effect of Age On Polysymptomatic Distress and Fibromyalgia: A Survey in a Representative Population Sample

    Winfried Häuser1, Frederick Wolfe2, Johannes Rasker3, Elmar Brähler4 and Heide Glaesmer4, 1Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany, 2National Data Bank for Rheumatic Diseases, Wichita, KS, 3Dpt. Psychology, Health and Technology, University Twente, Enschede, Netherlands, 4University of Leipzig, Leipzig, Germany

    Background/Purpose : Recent advances in the definition of the fibromyalgia syndrome (FM) have led to the development of the polysymptomatic distress (PSD) scale, providing a…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology